IL-1 induces mitochondrial translocation of IRAK2 to suppress oxidative metabolism in adipocytes
Hao Zhou,Han Wang,Minjia Yu,Rebecca C. Schugar,Wen Qian,Fangqiang Tang,Weiwei Liu,Hui Yang,Ruth E. McDowell,Junjie Zhao,Ji Gao,Ashok Dongre,Julie A. Carman,Mei Yin,Judith A. Drazba,Robert Dent,Christopher Hine,Yeong-Renn Chen,Jonathan D. Smith,Paul L. Fox,J. Mark Brown,Xiaoxia Li
DOI: https://doi.org/10.1038/s41590-020-0750-1
IF: 30.5
2020-08-10
Nature Immunology
Abstract:Chronic inflammation is a common feature of obesity, with elevated cytokines such as interleukin-1 (IL-1) in the circulation and tissues. Here, we report an unconventional IL-1R–MyD88–IRAK2–PHB/OPA1 signaling axis that reprograms mitochondrial metabolism in adipocytes to exacerbate obesity. IL-1 induced recruitment of IRAK2 Myddosome to mitochondria outer membranes via recognition by TOM20, followed by TIMM50-guided translocation of IRAK2 into mitochondria inner membranes, to suppress oxidative phosphorylation and fatty acid oxidation, thereby attenuating energy expenditure. Adipocyte-specific MyD88 or IRAK2 deficiency reduced high-fat-diet-induced weight gain, increased energy expenditure and ameliorated insulin resistance, associated with a smaller adipocyte size and increased cristae formation. IRAK2 kinase inactivation also reduced high-fat diet-induced metabolic diseases. Mechanistically, IRAK2 suppressed respiratory super-complex formation via interaction with PHB1 and OPA1 upon stimulation of IL-1. Taken together, our results suggest that the IRAK2 Myddosome functions as a critical link between inflammation and metabolism, representing a novel therapeutic target for patients with obesity.
immunology